Scott & Selber Inc. decreased its stake in UnitedHealth Group Inc (NYSE:UNH) by 1.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,521 shares of the healthcare conglomerate’s stock after selling 265 shares during the period. Scott & Selber Inc.’s holdings in UnitedHealth Group were worth $2,844,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of UNH. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group during the 2nd quarter worth $110,000. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth $121,000. Finally, Acrospire Investment Management LLC boosted its stake in UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after purchasing an additional 400 shares during the period. Institutional investors and hedge funds own 86.01% of the company’s stock.
UnitedHealth Group Inc (NYSE:UNH) opened at $224.20 on Thursday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market cap of $216,770.00, a PE ratio of 25.48, a PEG ratio of 1.57 and a beta of 0.66. UnitedHealth Group Inc has a twelve month low of $156.09 and a twelve month high of $231.77.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a $0.75 dividend. The ex-dividend date was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. UnitedHealth Group’s dividend payout ratio is presently 34.09%.
In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the transaction, the insider now directly owns 24,630 shares in the company, valued at approximately $5,060,726.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock valued at $7,669,416 in the last quarter. Insiders own 0.89% of the company’s stock.
UNH has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price for the company in a research note on Thursday, September 21st. Citigroup raised their target price on shares of UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Leerink Swann restated a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Cantor Fitzgerald restated a “buy” rating and issued a $208.00 target price on shares of UnitedHealth Group in a research note on Tuesday, October 17th. Finally, Jefferies Group raised their target price on shares of UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. Three analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $226.74.
TRADEMARK VIOLATION WARNING: This report was reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.com-unik.info/2018/01/11/unitedhealth-group-inc-unh-shares-sold-by-scott-selber-inc.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
What are top analysts saying about UnitedHealth Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group and related companies.